Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer-Reference-Cited by-同舟云学术

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer

Author:

Carbonnier Vincent¹,Le Naour Julie¹,Bachelot Thomas²,Vacchelli Erika¹³,André Fabrice⁴⁵,Delaloge Suzette⁶,Kroemer Guido¹³⁷^ORCID

Affiliation:

1. Equipe labellisée par la Ligue contrele cancer, Université de Paris, Sorbonne Université, Paris, France

2. Centre Léon Bérard, Département de Cancérologie Médicale, Lyon, France

3. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France

4. Université Paris Saclay, Faculty of Medicine Kremlin Bicêtre, Le Kremlin Bicêtre, France

5. Department of Medical Oncology, INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France

6. Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France

7. Hôpital Européen Georges Pompidou, AP-HP, Paris, France

Funder

Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Tollys, and Vascage

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

Reference51 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Immunosurveillance in clinical cancer management;CA: A Cancer Journal for Clinicians;2023-10-25